Fundraising FoxBold Capital Partners — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.
AI & Machine LearningHealthtechMedical DevicesSeattle, US
Gabriel Jones(Co-founder & CEO)inSamuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in
Co-investorsCota CapitalDCVC (Data Collective)Bird B. AGHTCPresence CapitalBOLD Longevity+4 more
Elevian is a biotechnology company developing rGDF11, a recombinant protein therapy shown in preclinical animal models to promote recovery of motor function after ischemic and hemorrhagic stroke by stimulating new blood vessel formation, neurogenesis, and reducing inflammation.
BiotechHealthtechLongevityMenlo Park, US
Mark Allen(Executive Officer, Director)inCasey J McGlynn(Executive Officer)Sebastian Giwa(Executive Officer, Director)inLuis Alvarez(Executive Officer)Daniel Marshak(Director)
BoardSuzanne Fletcher(Director)
Co-investorsThynk CapitalWestern Technology InvestmentFor Good VenturesLauder PartnersPrime Movers Lab
Near Space Labs provides high-resolution 7cm geospatial imagery captured from stratospheric altitudes, serving government, utilities, insurance, and environmental monitoring applications with frequent data refresh cycles and wide-scale coverage.
Climate TechData & InfrastructureSpace TechBrooklyn, US
Rema Matevosyan(Founder)inHripsime Matevosyan(Executive Officer, Director)Albert Caubet Domingo(Director)Asa B.in
Co-investorsAt One VenturesBlackhorn VenturesCrosscourt VenturesCrosslink CapitalDraper AssociatesGaingels+10 more
__Twitter.png)
Symbiome develops skin microbiome-based wellness products that restore ancestral skin health through proprietary fermentation and Amazonian botanical ingredients.
ConsumerHealthtechWellness & FitnessSan Francisco, US
Larry Weiss(Executive Officer, Director)Adam Klausner(Executive Officer)Vicki Levine(Executive Officer, Director)
BoardAdam D'Augelli(Director)in
Co-investorsMission BiocapitalGISEV Family OfficeMission Bay CapitalTrue Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
C19Ultraviolet Social
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.